[{"NetIncomeLoss_1_Q1_USD":-43733000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":6954000.0,"Assets_0_Q1_USD":249819000.0,"CommonStockSharesIssued_0_Q1_shares":19192805.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":3062000.0,"AssetsCurrent_0_Q1_USD":225965000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-3955000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":663650.0,"StockIssuedDuringPeriodValueNewIssues_17_Q1_USD":356700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1658000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":13628000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":19131557.0,"GeneralAndAdministrativeExpense_1_Q1_USD":15273000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":404000.0,"ShareBasedCompensation_1_Q1_USD":3062000.0,"Liabilities_0_Q1_USD":101901000.0,"OtherAssetsNoncurrent_0_Q1_USD":6154000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1362000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-36779000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-43733000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":404000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-6479000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":37000.0,"LongTermNotesPayable_0_Q1_USD":9136000.0,"CommonStockValue_0_Q1_USD":192000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-5245000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":121000.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-1669000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":19943000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":217081000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommonStockSharesAuthorized_0_Q1_shares":30000000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":440000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"AdditionalPaidInCapital_0_Q1_USD":459937000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q1_USD":-43733000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":8884000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":217081000.0,"LiabilitiesCurrent_0_Q1_USD":22211000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-34716000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":6954000.0,"Goodwill_0_Q1_USD":17260000.0,"CommonStockSharesOutstanding_0_Q1_shares":19192805.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-34191000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-310553000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":115000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-1714000.0,"AccretionExpense_1_Q1_USD":3100000.0,"StockholdersEquity_0_Q1_USD":147918000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1966000.0,"OperatingIncomeLoss_1_Q1_USD":-39778000.0,"AccountsPayableTradeCurrent_0_Q1_USD":6577000.0,"NotesPayableCurrent_0_Q1_USD":600000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":35.49,"PreferredStockValue_0_Q1_USD":null,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-152000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":249819000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3062000.0,"OperatingExpenses_1_Q1_USD":41744000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.29,"ProfitLoss_1_Q1_USD":-43733000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3441000.0,"OtherLiabilitiesCurrent_0_Q1_USD":1406000.0,"PreferredStockSharesAuthorized_0_Q1_shares":50000000.0,"OtherOperatingIncomeExpenseNet_1_Q1_USD":-6528000.0,"Ticker":"ALBO","CIK":"1322505","name":"ALBIREO PHARMA, INC.","OfficialName":"Albireo Pharma Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"688702712.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]